How should expiry, packaging and single use be checked on a filler syringe?

Outer carton, sterile barrier, syringe label, lot, expiry, storage condition and opening time form one filler traceability chain. An intact-looking carton cannot prove that the inner barrier is intact, and residual product should not be saved for another person or a later session.

This translation has no recorded clinical or medical-language review.

Direct answer

Open the product in front of the patient and match syringe details to the carton.
Do not use a damaged, previously opened, unlabeled or expired product.
Residual product in a single-use syringe cannot be resterilized or shared.

Match three label levels

Compare trade name, manufacturer, material and concentration, syringe volume, lot or serial and expiry across the carton, sterile pack and syringe. A different syringe placed inside a branded carton is not acceptable. Verify current Turkish registration and instructions separately through an official source; authorization in another jurisdiction does not establish local permission.

Sterile barrier and storage

Quarantine a product with a tear, puncture, moisture, leakage, loose cap, broken seal, unreadable label or unusual appearance. Limits for heat, cold, light and freezing vary by instructions, so the clinic should retain delivery and temperature records. A valid expiry date cannot correct improper storage or a compromised sterile barrier.

One patient and one procedure chain

A prefilled filler syringe is single-use according to its specific labeling. Changing the needle does not make residual product safe for another patient, while retaining an opened syringe for a later visit makes sterility and traceability uncertain. Record lot and amount in the patient file, provide a label copy when appropriate, and discard residual material through the medical-waste process.

Scope of this article

This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.

Sources and evidence limits

These links are editorial starting points used to examine the article's boundaries.

Dermal Fillers (Soft Tissue Fillers)
U.S. Food and Drug Administration (FDA) · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Guideline for the Management of Hyaluronic Acid Filler-Induced Vascular Occlusion
Gillian Murray, Cormac Convery, Lee Walker, Emma Davies; Complications in Medical Aesthetics Collaborative (CMAC) · 2021
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Safety and Potential Complications of Facial Wrinkle Correction with Dermal Fillers: A Systematic Literature Review
Audra Janovskiene, Deividas Chomicius, Dominykas Afanasjevas, Zygimantas Petronis, Dainius Razukevicius, Egle Jagelaviciene · 2024
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
BELOTERO VOLUME (+) Lidocaine — Instructions for Use
FDA device labeling / Merz North America · 2026
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Dermal Filler Do's and Don'ts for Wrinkles, Lips and More
U.S. Food and Drug Administration (FDA) · 2026
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review